Similar Gut Hormone Secretions Two Years After One Anastomosis Gastric Bypass and Roux-en-Y Gastric Bypass: a Pilot Study

被引：0

作者：

David De Bandt

Claire Rives-Lange

Yvann Frigout

Damien Bergerot

Anne Blanchard

Maude Le Gall

Jean-Marc Lacorte

Jean-Marc Chevallier

Sébastien Czernichow

Tigran Poghosyan

Claire Carette

Johanne Le Beyec

机构：

[1] AP-HP,INSERM, UMR 1149 Centre de Recherche Sur L’Inflammation

[2] Hôpital Européen Georges-Pompidou,undefined

[3] Nutrition,undefined

[4] APHP.Centre - Université de Paris,undefined

[5] AP-HP,undefined

[6] Hôpital Européen Georges-Pompidou,undefined

[7] Unité de Recherche Clinique,undefined

[8] APHP.Centre - Université de Paris,undefined

[9] INSERM,undefined

[10] Centre d’Investigation Clinique 1418,undefined

[11] Hôpital Européen Georges-Pompidou,undefined

[12] APHP.Centre - Université de Paris,undefined

[13] Université de Paris,undefined

[14] AP-HP,undefined

[15] Hôpital Pitié-Salpêtrière,undefined

[16] Biochimie Endocrinienne Et Oncologique,undefined

[17] AP-HP,undefined

[18] Hôpital Européen Georges-Pompidou,undefined

[19] Chirurgie digestive,undefined

[20] APHP.Centre - Université de Paris,undefined

来源：

Obesity Surgery | 2022年 / 32卷

关键词：

GLP-1; GIP; Gut hormones; One anastomosis gastric bypass; Roux-en-Y gastric bypass;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：757 / 762

页数：5

共 87 条

[1] Rubino F(2016)Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by International Diabetes Organizations Diabetes Care 39 861-877
[2] Nathan DM(2019)Chirurgie bariatrique : état des lieux en France en 2019 Médecine des Maladies Métaboliques 13 677-686
[3] Eckel RH(2020)Leveraging the gut to treat metabolic disease Cell Metab 31 679-698
[4] Schauer PR(2019)Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial Lancet 393 1299-1309
[5] Alberti KGMM(2011)Roux-en-Y Gastric Bypass Corrects Hyperinsulinemia Implications for the Remission of Type 2 Diabetes J Clin Endocrinol Metab 96 2525-2531
[6] Zimmet PZ(2017)Intestinal adaptations following bariatric surgery: towards the identification of new pharmacological targets for obesity-related metabolic diseases Curr Opin Pharmacol 37 29-34
[7] Halimi S(2014)Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect Obes Surg 24 1552-1562
[8] Gimeno RE(2017)Impact of bariatric surgery on metabolic and gut microbiota profile: a systematic review and meta-analysis Obes Surg 27 1345-1357
[9] Briere DA(2019)One anastomosis gastric bypass versus Roux-en-Y gastric bypass for morbid obesity: an updated meta-analysis Obes Surg 29 2721-2730
[10] Seeley RJ(2014)Incretin levels 1 month after laparoscopic single anastomosis gastric bypass surgery in non-morbid obese type 2 diabetes patients Asian J Surg 37 130-137

← 1 2 3 4 5 6 7 8 9 →